Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cellsA model for immunotherapy

Experimental Hematology

Volumn 29, Issue 8, 2001, Pages 952-961

  Dotti, G ^a   Savoldo, B ^a   Takahashi, S ^a   Goltsova, T ^a   Brown, M ^a   Rill, D ^a   Rooney, C ^a   Brenner, M ^a  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39; VIRUS VECTOR;

ADENOVIRUS; ANTIGEN PRESENTING CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; GENE TRANSFER; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOPHENOTYPING; IN VITRO STUDY; ISOTOPE LABELING; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; STAINING;

ADENOVIRIDAE; ANTIGENS, CD; APOPTOSIS; CD40 LIGAND; COCULTURE TECHNIQUES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOPHENOTYPING; IMMUNOTHERAPY; LUMINESCENT PROTEINS; LYMPHOCYTE CULTURE TEST, MIXED; MODELS, IMMUNOLOGICAL; MULTIPLE MYELOMA; RECOMBINANT PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0034909827     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00668-3     Document Type: Article

References (34)

1. Tumor immunology; the glass is half full
2. + T cells by B-7 transected melanoma cells
3. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?
4. Costimulation of antitumor immunity by the B7 counter receptor for the T lymphocyte molecules CD28 and CTLA-4
5. Maturation of cytotoxic T lymphocytes against a B7-transfected nonmetastatic tumor; a crucial role of costumulation by B7 on both tumor and host antigen-presenting cells
6. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependant signal
7. Follicular lymphomas can be induced to present alloantigen efficiently; a conceptual model to improve their tumor immunogenicity
8. CD40 ligand induces an antileukemia immune response in vivo
9. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells
10. + T cells in the antitumor immune response
11. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
12. 5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
13. Generation of tumor-specific T lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells
14. Dendritic cells and the control of immunity
15. Dendritic cells; unique leukocytes populations which control the primary immune response
16. Activation of human dendritic cells through CD40 cross-linking
17. + T-helper and T-killer cell
18. CD40 expression in malignant plasma cells
19. Expression of CD28 and CD40 in human myeloma cells; a comparative study with normal plasma cells
20. Anti-CD40 antibody binding modulates human multiple myeloma clonogenicity in vitro
21. CD40 ligand-induced apoptosis is Fas-independent in human multiple myeloma cells
22. CD40 ligand triggered interleukin-6 secretion in multiple myeloma
23. CD11a-CD18 and CD102 interaction mediate human myeloma cell growth arrest induced by CD40 stimulation
24. CD40 activation mediates p53-dependent cell cycle regulation in human multiple myeloma cell lines
25. Sensitivity and reproducibility in adenoviral infectious titer determination
26. Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins
27. Muc-1 core protein is expressed on multiple myeloma cells and is induced by dexamethasone
28. Genes encoding tumor-specific antigens are expressed in human myeloma cells
29. Idiotype vaccination in human myeloma; generation of tumor-specific immune responses after high-dose chemotherapy
30. Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma-a feasibility study
31. CD40 and CD95 induce programmed cell death in the human myeloma cell XG2
32. Anti-tumor immunity induced by in vivo adenovirus vector-mediated expression of CD40 ligand in tumor cells